Market overview
The global tangential flow filtration market is worth USD 2.5 bn in 2026 and is forecast to reach USD 5.9 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Cassettes and filters is the largest by product segment.
| Scope | Tangential flow filtration systems, cassettes, hollow fibres and consumables used to concentrate and purify biologics, vaccines and cell therapies. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 2.3 bn |
| Value 2026 | USD 2.5 bn |
| Value 2036 | USD 5.9 bn |
| CAGR 2026-2036 | 9.0% |
| Volume 2026 | 174 thousand units |
| Volume 2036 | 391 thousand units |
| Average price 2026 | USD 14,450 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Tangential Flow Filtration market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 2.5 bn |
| 2027 | USD 2.7 bn |
| 2028 | USD 3.0 bn |
| 2029 | USD 3.2 bn |
| 2030 | USD 3.5 bn |
| 2031 | USD 3.9 bn |
| 2032 | USD 4.2 bn |
| 2033 | USD 4.6 bn |
| 2034 | USD 5.0 bn |
| 2035 | USD 5.4 bn |
| 2036 | USD 5.9 bn |
Tangential Flow Filtration market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Cassettes and filters | 44.0% | 42.5% | USD 1.1 bn | 8.6% |
| Systems and skids | 26.0% | 24.0% | USD 652 mn | 8.1% |
| Hollow fibre | 18.0% | 20.9% | USD 451 mn | 10.6% |
| Accessories and services | 12.0% | 12.7% | USD 301 mn | 9.6% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Monoclonal antibodies | 40.0% | 35.6% | USD 1.0 bn | 7.8% |
| Vaccines | 20.0% | 19.5% | USD 501 mn | 8.8% |
| Cell and gene therapy | 18.0% | 25.2% | USD 451 mn | 12.7% |
| Other biologics | 22.0% | 19.6% | USD 552 mn | 7.8% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Biopharma manufacturers | 62.0% | 58.8% | USD 1.6 bn | 8.4% |
| Contract manufacturers | 24.0% | 27.3% | USD 602 mn | 10.4% |
| Research institutes | 14.0% | 13.9% | USD 351 mn | 8.9% |
By format
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Single-use | 40.0% | 48.0% | USD 1.0 bn | 11.0% |
| Reusable stainless | 38.0% | 30.0% | USD 953 mn | 6.5% |
| Hybrid systems | 22.0% | 22.0% | USD 552 mn | 9.0% |
By membrane
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Polyethersulfone | 42.0% | 42.0% | USD 1.1 bn | 9.0% |
| Regenerated cellulose | 34.0% | 32.0% | USD 852 mn | 8.3% |
| Other polymeric | 24.0% | 26.0% | USD 602 mn | 9.9% |
Top 25 countries for tangential flow filtration by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 86.5% of 2026 revenue and the 25 countries below together hold 96.2%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 953 mn | 38.0% | USD 2.1 bn | 8.3% |
| 2 | Germany | USD 226 mn | 9.0% | USD 504 mn | 8.4% |
| 3 | China | USD 226 mn | 9.0% | USD 724 mn | 12.4% |
| 4 | Switzerland | USD 150 mn | 6.0% | USD 332 mn | 8.2% |
| 5 | Japan | USD 125 mn | 5.0% | USD 255 mn | 7.4% |
| 6 | United Kingdom | USD 125 mn | 5.0% | USD 279 mn | 8.3% |
| 7 | South Korea | USD 100 mn | 4.0% | USD 279 mn | 10.8% |
| 8 | France | USD 100 mn | 4.0% | USD 214 mn | 7.9% |
| 9 | Ireland | USD 88 mn | 3.5% | USD 196 mn | 8.4% |
| 10 | India | USD 75 mn | 3.0% | USD 243 mn | 12.5% |
| 11 | Canada | USD 54 mn | 2.2% | USD 120 mn | 8.3% |
| 12 | Netherlands | USD 32 mn | 1.3% | USD 71 mn | 8.2% |
| 13 | Spain | USD 24 mn | 0.9% | USD 53 mn | 8.3% |
| 14 | Belgium | USD 19 mn | 0.8% | USD 43 mn | 8.4% |
| 15 | Denmark | USD 16 mn | 0.7% | USD 36 mn | 8.3% |
| 16 | Sweden | USD 14 mn | 0.6% | USD 31 mn | 8.4% |
| 17 | Singapore | USD 13 mn | 0.5% | USD 40 mn | 12.2% |
| 18 | Taiwan | USD 11 mn | 0.5% | USD 26 mn | 8.5% |
| 19 | Italy | USD 11 mn | 0.4% | USD 23 mn | 8.2% |
| 20 | Israel | USD 9.5 mn | 0.4% | USD 30 mn | 12.2% |
| 21 | Mexico | USD 9.0 mn | 0.4% | USD 28 mn | 12.2% |
| 22 | Brazil | USD 8.5 mn | 0.3% | USD 27 mn | 12.1% |
| 23 | Austria | USD 8.0 mn | 0.3% | USD 18 mn | 8.3% |
| 24 | Turkey | USD 7.5 mn | 0.3% | USD 24 mn | 12.2% |
| 25 | Australia | USD 7.0 mn | 0.3% | USD 16 mn | 8.6% |
| Rest of world | USD 95 mn | 3.8% | USD 198 mn | 7.6% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Cytiva
- Sartorius
- Merck KGaA
- Repligen
- Pall
Group 2: Regional and specialist players
- Asahi Kasei Bioprocess
- Parker Hannifin
- Avantor
- Koch Separation Solutions
- Novasep
- Cobetter Filtration
- Microdyn-Nadir
Group 3: Emerging and niche players
- Sterlitech
- Synder Filtration
- Pendotech
- Axiva Sichem Biotech
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the tangential flow filtration market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 9.0% is calculated from the resulting values.
The market is divided by product, by application, by end user, by format, by membrane. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the tangential flow filtration market?
The global tangential flow filtration market is estimated at USD 2.3 bn in 2025 and USD 2.5 bn in 2026.
How fast will the tangential flow filtration market grow?
It is forecast to reach USD 5.9 bn by 2036, a compound annual growth rate of 9.0% from 2026, an increase of USD 3.4 bn.
Which country is the largest market for tangential flow filtration?
United States is the largest market by revenue at USD 953 mn in 2026, 38.0% of the global total. The three largest countries together hold 56.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 12.5% a year from 2026 to 2036.
Which tangential flow filtration segment is largest?
In the by product split, Cassettes and filters is the largest segment with 44.0% of 2026 revenue.
Who are the leading tangential flow filtration companies?
Global leaders include Cytiva, Sartorius, Merck KGaA, Repligen.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Cardiovascular Drug DiscoveryUSD 2.6 bn · 7.5% CAGR
- Chromatography ResinUSD 2.6 bn · 9.8% CAGR
- 3D Cell CultureUSD 2.7 bn · 12.0% CAGR
- Medical CannulaUSD 2.3 bn · 5.3% CAGR
- Laboratory Information Management SystemUSD 2.7 bn · 9.5% CAGR
- Gene SynthesisUSD 2.8 bn · 15.0% CAGR
- Point-of-Care Respiratory Diagnostic PanelsUSD 2.2 bn · 6.5% CAGR
- CRISPR and Cas GeneUSD 2.9 bn · 13.5% CAGR